AMGN SEC Filings: 8-K, 10-Q, S-3 & 424B – Amgen

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 4, 2026

11-K

Form 11-K - Annual report of employee stock purchase, savings and similar plans

Jun 11, 2026

11-K

Form 11-K - Annual report of employee stock purchase, savings and similar plans

Jun 11, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Apr 30, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 13, 2026

News

TYPE

HEADLINE

FILED AT

8-K

Amgen Reports Third Quarter 2026 Financial Results

Nov 3, 2026

8-K

AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS

Oct 26, 2026

8-K

Amgen Reports Second Quarter 2026 Financial Results

Aug 4, 2026

8-K

Amgen Reports Material Cybersecurity Incident Involving Data Exfiltration

Jul 31, 2026

8-K

Amgen Inc. Announces Results of 2026 Annual Meeting of Stockholders

May 20, 2026

8-K

Amgen Announces Retirement of CFO Peter Griffith and Appointment of Thomas Dittrich

May 19, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Feb 18, 2026

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Feb 17, 2026

424B2

Common Stock

Feb 16, 2023

424B3

Common Stock

Feb 14, 2023

424B2

Common Stock

Aug 16, 2022

424B3

Common Stock

Aug 15, 2022

Registrations

TYPE

HEADLINE

FILED AT

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 17, 2026

S-3ASR

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 13, 2026

S-8

Registration

Jun 12, 2024

S-8

Registration

Oct 6, 2023

FWP

$2,000,000,000 5.250% Senior Notes due 2025 (the “2025 Notes”)

Feb 15, 2023

S-3ASR

Common Stock

Feb 9, 2023

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A